[Janus-faced character of chemotherapy: a comment on the Abel theses].
Schmähl
D
D
Institut für Toxikologie und Chemotherapie, Deutsches Krebsforschungszentrum, Heidelberg.
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000529:Complementary Therapies; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis; D015996:Survival Rate
D000970:Antineoplastic Agents